[Eosinophilia in acute lymphoblastic leukemia and lymphosarcoma: indicator of immune responses? (author's transl)].
D000917:Antibody Formation; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D012075:Remission, Spontaneous
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents
Eosinophilie bei akuter lymphoblastischer Leukämie und Lymphosarkom: Indikator für immunologische Vorgänge?